POWAY, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. announced today that it has acquired the business of Alfa Wassermann Diagnostic Technologies LLC. (AWDT) from CARR Biosystems. AWDT is an FDA registered manufacturer and seller of chemistry systems and reagents. Founded in 1960 and headquartered in West Caldwell, New Jersey, AWDT’s business will be integrated into Diazyme’s operations.

“Alfa Wassermann Diagnostic Technologies strengthens Diazyme’s ability to serve customers through a strong nationwide customer support network, wide instrumentation placement, and a demonstrated commitment to service excellence,” said Dr. Chong Yuan, Managing Director of Diazyme Laboratories. “Through trusted relationships and highly trained technical-support team, Diazyme will be better positioned to expand access to reliable, accurate testing solutions and support physicians, veterinarians, researchers, and laboratories in making timely, informed decisions.” Mr. Peter Napoli, CEO of Alfa Wassermann Diagnostics Technologies, said joining Diazyme is synergistic for Alfa Wassermann, and will help provide better services and test menu to our customers”. Mr. Napoli, will continue to manage Alfa Wassermann Diagnostic Technologies business as part of Diazyme’s management team.

Globenewswire